While FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.
FDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen (epinephrine auto-injector).
A top-selling diabetes drug has gained a cardiovascular indication from FDA.
FDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
FDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Novo Nordisk’s DEVOTE study reveals interesting findings.
FDA approves new diagnostic test for non-small cell lung cancer.